NCT00320918终止不适用
Chart Review on Patients With Unresectable/Metastatic Cholangiocarcinoma Treated in the UNM Cancer Center With a Combination of Irinotecan, Capecitabine and Celecoxib
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 10
- 试验地点
- 1
研究概览
简要总结
Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
详细描述
As above.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
排除标准
- •Not specified.
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver MetastasesLiver MetastasesColorectal CancerNCT02864485University Health Network, Toronto20
招募中
1/2 期
Multicentric randomized phase I / II study to evaluate efficacy of trifluridine/tipiracil +/- bevacizumab plus XB2001 (anti-IL-1α True Human antibody) versus trifluridine/tipiracil +/- bevacizumab plus placebo in metastatic colorectal cancer patients after failure of oxaliplatin, irinotecan, fluoropyrimidine2024-517024-20-00Centr Georges Francois Leclerc190
已完成
2 期
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With CholangiocarcinomaCholangiocarcinomaNCT02181634PrECOG, LLC.74
Unknown
不适用
Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation ProjectLiver MetastasesColorectal CancerNCT01815879Andrew Kennedy1,000
已完成
不适用
Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4Colon CancerNCT02305368University Hospital, Limoges20